Keywords: Johnson & Johnson, First-quarter 2010, Truvada, Gilead

J&J posts higher first-quarter 2010 profit, boosted by one-time gain, but lowers forecast; updates on Truvada combo n HIV

Article | 21 April 2010

Print This

US health care giant Johnson & Johnson reported that first-quarter 2009 profit rose 29% to $4.53 billion, or $1.62 per share, mainly as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in